January 15, 2020
Dalton Pharma Services, has received a three-year renewal and license amendment of its Cannabis Act Processing License from Health Canada.
December 18, 2019
Cardiol Therapeutics Inc. is pleased to announce that it has appointed Michael J. Willner, Esq. as Business Advisor to the...
December 3, 2019
Cardiol Therapeutics Inc. is pleased to announce the appointment of Mr. Colin Stott to its Board of Directors, effective immediately.
November 27, 2019
Diligent CBD testing and oversight could be the key to sustained industry growth and consumer health in North American cannabis.
November 25, 2019
Cardiol Therapeutics Inc. commented on Purisys, LLC's news release issued on November 21st.
November 19, 2019
Cardiol Therapeutics Inc. is pleased to announce the formation of the Clinical Steering Committee for a Phase 2 international trial.
October 1, 2019
Cardiol Therapeutics Inc., announces that it has completed the manufacturing scale-up for commercialization of its CardiolRx™100 CBD formulation.